PrimeRFP SCOUT · Federal Contract Recompete Brief

36C77021N0219Pharmaceutical - valbenazine 80mg ORAL capsules — Neurocrine Biosciences, Inc

Public-record facts for this award are shown above. Open SCOUT for live scoring relative to your firm, watchlists, and capture workflow.

National Cmop Office (36C770)

Awarding office

Neurocrine Biosciences, Inc

Recipient

—

Estimated value

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal

Contract number36C77021N0219

Also listed as36C770-21-N-0219

AgencyNational Cmop Office (36C770)

Awarding officeNational Cmop Office (36C770)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentNeurocrine Biosciences, Inc

UEIGMQSH4CZ7EC9

PSC6505

PHARMACEUTICAL - VALBENAZINE 80MG ORAL CAPSULES FOR HINES CMOP is a federal award for National Cmop Office (36C770) held by Neurocrine Biosciences, Inc. Estimated value —.

PHARMACEUTICAL - VALBENAZINE 80MG ORAL CAPSULES FOR HINES CMOP

Bonuses end Sept 30

Want the durability read on 36C77021N0219? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C77021N0219?

36C77021N0219 (Pharmaceutical - valbenazine 80mg ORAL capsules) is a National Cmop Office (36C770) award with an estimated value of —, currently held by Neurocrine Biosciences, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C770-21-N-0219?

36C770-21-N-0219 is the dashed form of PIID 36C77021N0219 (Pharmaceutical - valbenazine 80mg ORAL capsules), held by Neurocrine Biosciences, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C77021N0219?

National Cmop Office (36C770) awarded 36C77021N0219 to Neurocrine Biosciences, Inc.

Who is the incumbent on 36C77021N0219?

Neurocrine Biosciences, Inc is the incumbent.

When does Neurocrine Biosciences, Inc’s 36C77021N0219 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C77021N0219? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.